Suppr超能文献

摩那娑密陀罗丸草药成分治疗阿尔茨海默病的药理作用:综述

Pharmacological effects of herbal ingredients of Manasamitra vatakam in the treatment of Alzheimer's disease: A review.

作者信息

Nair Anju C, Kuriakose Beena Briget, Biju Aswini, Surendran Sarika, Sudheesh M S, Lakshmi P K

机构信息

Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, Kerala, 682041, India.

Department of Basic Medical Sciences, College of Applied Medical Sciences, King Khalid University, Khamis Mushayt, Kingdom of Saudi Arabia.

出版信息

J Ayurveda Integr Med. 2025 Jan-Feb;16(1):101041. doi: 10.1016/j.jaim.2024.101041. Epub 2025 Jan 11.

Abstract

Multi-targeted drug therapy has received substantial attention for the treatment of diseases of multi-factorial origin, including neurodegenerative and autoimmune diseases. It seems reasonable to argue that the complex pathology of neurodegenerative diseases (ND) cannot be reduced to a single target to modulate a broad range of cellular signaling, associated pathologies, and symptoms. It is this idea that has brought the attention of the scientific world towards phytochemicals and traditional drugs that are notoriously multi-targeted. A systematic study of these formulations and establishing the molecular pathways of individual molecules can lead to a standardized multi-component product that can modulate a broad range of activities on different targets of ND. This could provide an accessible and affordable solution to the significant disease burden of ND. With this idea in mind, a systematic review was carried out on an Ayurvedic product Manasamitra Vatakam (MMV), known to be a neuroprotective formulation and highly effective against Alzheimer's disease. MMV can be a source of phytomolecules for treating neurodegenerative diseases. The multifactorial nature of these diseases makes them suitable candidates for testing phytochemicals due to the inherent multitargeting capabilities of these compounds. The primary objective of this review is to provide a comprehensive understanding of the phytomolecules from MMV that are responsible for its multitargeted effect against neurodegenerative diseases. From the reported literature, it is clear that many phytoconstituents and extracts of the herbal ingredients from MMV have demonstrated their efficacy against AD models. However, the combination of these molecules in AD models has never been tested. Scientific studies should be done to explore the bioactive compounds in the formulation and the druggability of these identified compounds can be evaluated using experimental methods.

摘要

多靶点药物疗法在治疗包括神经退行性疾病和自身免疫性疾病在内的多因素起源疾病方面受到了广泛关注。有理由认为,神经退行性疾病(ND)的复杂病理不能简化为单一靶点来调节广泛的细胞信号传导、相关病理和症状。正是这一观点引起了科学界对众所周知的多靶点植物化学物质和传统药物的关注。对这些制剂进行系统研究并确定单个分子的分子途径,可以得到一种标准化的多组分产品,该产品可以调节对ND不同靶点的广泛活性。这可以为ND的重大疾病负担提供一种可及且负担得起的解决方案。基于这一想法,对一种阿育吠陀产品玛纳斯米特拉瓦塔卡姆(MMV)进行了系统综述,该产品已知是一种神经保护制剂,对阿尔茨海默病非常有效。MMV可以成为治疗神经退行性疾病的植物分子来源。这些疾病的多因素性质使其成为测试植物化学物质的合适候选者,因为这些化合物具有固有的多靶点能力。本综述的主要目的是全面了解MMV中负责其对神经退行性疾病多靶点作用的植物分子。从已发表的文献来看,很明显,MMV中许多草药成分的植物成分和提取物已在AD模型中证明了其功效。然而,这些分子在AD模型中的组合从未经过测试。应该开展科学研究来探索该制剂中的生物活性化合物,并可以使用实验方法评估这些已鉴定化合物的成药潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c7/11773069/ed3f23bde047/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验